New England Journal of Medicine recommends that EPA delays implementation of its decision to permit use of Enlist Duo and to label Genetically Modified food.

toxic chemicalA recommendation by the of Medicine has focused on the environmental and public safety hazard associated with genetically modified organisms. The vast majority of and soybeans grown in the are genetically engineered and the Food and Drug Administration () does not require labeling of .

The International Agency for Research on Cancer (IARC) has classified glyphosate, the most widely used on GM crops, as a “probable human carcinogen” and classified a second , 2,4-dichlorophenoxyacetic acid (2,4-D), as a “possible human carcinogen.”

The use of genetically modified crops has resulted in increased resistance resulting in considerable tolerance to glyphosate (Roundup). Roundup ready crops account for more than 90% of the planted in the and glyphosate use has increased by a factor of more than 250 to 113 million kg in 2014.

The () has approved the use of Enlist Duo, a combination comprising glyphosate plus 2,4-D to combat resistance. It will be marketed in tandem with newly approved seeds genetically engineered to resist glyphosate, 2,4-D, and multiple other herbicides. The has specified that it anticipates a 3-to-7-fold increase in 2,4-D use.

The of Medicine has offered two recommendations:

The should delay implementation of its decision to permit use of Enlist Duo and the National Toxicology Program should urgently assess the toxicology of pure glyphosate, formulated glyphosate, and mixtures of glyphosate and other herbicides.

The should label .


Be Sociable, Share!

    Leave a Reply

    Your email address will not be published. Required fields are marked *